1302 The therapeutic effect of glycolysis inhibition in lupus-prone mice is transferable through the fecal microbiome

• Laurence Morel,
• Seung-Chul Choi,
• Josephine Brown,
• Georges Abboud,
• Ahmed S Elshikha,
• Yong Ge,
• Nathalie Kanda,
• Timothy J Garrett,
• William Clapp,
• Mansour Zadeh

Affiliations

Laurence Morel

Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, Florida, USA

Seung-Chul Choi

Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA

Josephine Brown

Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA

Georges Abboud

2Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL, USA

Ahmed S Elshikha

1Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, Fl., USA

Yong Ge

2Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health San Antonio, Tx., USA

Nathalie Kanda

2Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health San Antonio, Tx., USA

Timothy J Garrett

1Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, Fl., USA

William Clapp

1Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, Fl., USA

Mansour Zadeh

2Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health San Antonio, Tx., USA